LUDGOTCServices-Medical LaboratoriesFiscal year ends December 31

LUDWIG ENTERPRISES, INC.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 29, 2026

$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $3.46M
P/E (TTM): –
Dividend yield: –

LUDWIG ENTERPRISES, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Revenue	–	0.00	–	–
Research & Development	0.23	0.17	0.41	0.11
General & Administrative	–	1.13	0.96	–
Advertising Expenses	0.26	0.22	0.14	0.08
Operating Expenses	1.77	1.30	1.38	–
Operating Income	-1.77	-1.30	-1.38	0.56
Interest Expense	0.09	0.06	0.02	0.01
Interest & Investment Income	0.01	–	–	–
Other Non-Operating Income	-0.46	-1.75	-1.00	-0.40
Gain (Loss) on Sale of Assets	–	0.20	–	–
Pretax Income	-2.24	-3.05	-2.38	-0.97
Income from Continuing Operations	-2.24	-3.05	-2.38	–
Income from Discontinued Operations	–	0.03	-0.08	–
Net Income incl. Noncontrolling Interests	–	–	-2.46	-0.97
Net Income	-2.24	-3.02	-2.46	-0.97
EPS (Basic)(per share)	-0.01	-0.02	-0.01	–
EPS (Diluted)(per share)	-0.01	-0.02	-0.01	–
Shares Outstanding (Basic, Weighted)(shares)	162	159	–	–
Shares Outstanding (Diluted, Weighted)(shares)	162	159	287	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: 66.1%

Financial strength

Current ratio: 0.05
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 0.3%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –